Louisiana Wholesale Drug Co. v. Bayer AG

Petition for certiorari denied on March 7, 2011
Docket No. Op. Below Argument Opinion Vote Author Term
10-762 2d Cir. N/A N/A N/A N/A OT 2010

Issue: Whether, absent patent fraud or sham litigation, a brand drug maker's substantial payment to a competing generic drug maker to forgo judicial testing of the patent and restrict entry is per se lawful under the Sherman Act.

Briefs and Documents

Certiorari-stage documents

 
Share:
Term Snapshot
Awards